In person and virtual
The TAP Life Sciences program by World Trade Centre Toronto empowers SMEs in the MedTech industry for strategic international growth. With top commercialization advisors, tailored coaching, and essential resources, it equips businesses to scale successfully.
This program, hosted in partnership with MaRS, is designed for leaders, CEOs, owners, and C-suite executives of Ontario-based MedTech companies. Over seven weeks, through a mix of virtual and in-person hands-on workshops and mentoring sessions, seasoned professionals help participants develop an effective commercialization strategy for international markets.
Canadian MedTech companies often secure their first clients internationally before establishing a significant presence in Canada. Early-stage ventures must quickly understand user, payer and regulatory preferences in global markets. Given the industry's rapid growth, international readiness is crucial for initial commercialization. Canadian companies must prioritize export readiness and international business skills early to succeed globally and build sustainable businesses.
Unlock Global Opportunities with TAP Life Sciences. This program is designed to equip SMEs in the Medical Technology industry with:
- Understanding key concepts in Medical Technology commercialization for international market access.
- Ensuring product meets healthcare needs and demonstrates value.
- Validating target markets and creating a tangible export plan to serve as a blueprint to support commercialization efforts.
- Creating profitable entities with a local and global customer base.
Contact:
Carissa Consoli
Senior Manager, Business Development
World Trade Centre Toronto
cconsoli@bot.com
The Trade Accelerator Program is supported by several partners, including Innovation, Science and Economic Development, in delivering Canada’s Export Diversification Strategy.
Agenda
Week 1: In-person
- Tuesday, December 10 (9 am - 5 pm): Mindsets and Blind Spots for Scaling Internationally
Week 2: Virtual
- December 17 & 19: EU & US Market Access Fundamentals
Week 3: In-person
- Tuesday, January 14 (9am - 5 pm): Understanding the Nuts & Bolts
Week 4: Virtual
- Tuesday, January 21: IP Protection and Commercialization of Medical Devices
- Friday, January 24: IP, Privacy, & Commercialization
Week 5: In-person
- Wednesday, January 29 (9 am - 5 pm): Show me the money!
- Export Plan Due: February 11
Week 6: Virtual
- Tuesday, February 4: Financial Strategies
Week 7: Virtual
- February 25: One-on-one mentoring
Speakers
-
Shahira Bhimani
Health Innovation Consultant Co-Chair, National Digital Health Task Force, Medtech Canada
-
Gabriella Farcas Chan
Founder, Yocto Law
-
Dr. Joseph Ferenbok
Associate Professor and Director Translational Research Program, University of Toronto
-
Stephen Hull
Senior VP Market Access, Hull Associates, an Avania Company
-
Dan Juskovic
Vice President, Life Sciences and Healthcare, RBCx
-
Nick Kuryluck
Co-Founder, CoSality Executive Partners & Virtus Insights Inc.
-
Thomas Meier
Managing Director, You-Can.Biz
-
Abood Mohamed
Vice President, Banking, RBCx
-
Hamid Sadri
Senior Director Market Access, Health Economics and Outcomes Research, Medtronic
-
Frank Shannon
Vice President Clinical Development & Regulatory Affairs, Sernova Corp.
-
Melanie Szweras
Principal, Smart & Biggar LLP
-
Harold Wodlinger
Independent Consultant & Chairman of the Board, Exact Imaging
Tickets & Registration
Eligibility Criteria
- Life sciences companies post-seed with over $1 million in non-dilutive and equity financing.
- Have a differentiated and validated technology or product with market traction, including at least a minimum viable product and quantifiable evidence of maturity (revenue, number of users, investment, or TRL 6 or greater).
- Can demonstrate product-market fit by defining the target audience and the problem being solved.
- Have a passionate, strong, and committed management team with at least one senior manager (C-level or founder) who can commit to participating in the entire program, and a seasoned advisory board.
- Demonstrate readiness to talk with potential partners.
- Demonstrate financial resources to cover in-market costs.
- Registered as a business in Canada
Apply for the session
TAP is designed for export-ready companies meeting the eligibility requirements outlined above. Your application will be reviewed by one of our team members, who will connect with you within 3-5 business days to discuss your program status.